P09.01 Adoptive cell therapy of hematological malignancies using cytokine-induced killer cells retargeted with monoclonal antibodies

作者
Anna Dalla Pietà,Elisa Cappuzzello,Pierangela Palmerini,Roberta Sommaggio,Giuseppe Astori,Katia Chieregato,Omar Perbellini,Maria Chiara Tisi,Carlo Visco,Marco Ruggeri,Antonio Rosato
出处
期刊:Journal for ImmunoTherapy of Cancer [BMJ]
卷期号:: A51.2-A52
标识
DOI:10.1136/jitc-2020-itoc7.101
摘要

Background Cytokine-Induced Killer (CIK) cells are a population of effector cells that represents a promising tool for adoptive cell therapy. They are easily expandable ex-vivo, safe, and exert cytotoxicity against a broad range of tumor histotypes.1 We recently reported that they have a relevant expression of FcγRIIIa (CD16a), which can be exploited in combination with clinical-grade monoclonal antibodies (mAbs) to redirect their cytotoxicity in an antigen-specific manner, to improve their antitumor activity.2 Indeed, the engagement of CD16a on CIK cells leads to a potent antibody-dependent cell-mediated cytotoxicity (ADCC) against ovarian cancer both in vitro and in vivo. Based on this observation, we investigated whether CIK cells can be specifically retargeted against B-cell malignancies by combination with anti-CD20 mAbs, namely Rituximab® (RTX) and Obinutuzumab® (OBI). Materials and Methods CIK cells were obtained from peripheral blood mononuclear cells of healthy donors, and stimulated in vitro with IFN-γ, CD3 mAb and IL-2 for 14 days; fresh IL-2 was provided every 3–4 days. CIK cell phenotype was analyzed by multicolor flow cytometry; cytotoxic activity was assessed by calcein AM-release assay against B-cell lines, primary samples and patient-derived xenografts (PDX) obtained from B-cell lymphoma patients after written informed consent. Results The combination with both RTX and OBI significantly increased specific CIK cells lysis against several CD20-expressing lymphoma B cell lines, primary tumors from B-cell lymphoma patients and an established PDX, compared to the combination with a control mAb (cetuximab, CTX). NK-depletion demonstrated that the mAb-mediated cytotoxicity is accountable to the CIK cells fraction within the bulk population since no difference in the lytic activity was detectd in the absence of NK cells. In addition, these results are further supported by in vivo preliminary experiments where the treatment with CIK cells in combination with OBI extensively reduced the growth of PDX and increased mice survival, compared to CIK cells or OBI administered alone. Conclusions Here we proved that CIK cells can be retargeted with clinical-grade mAbs against CD20-expressing lymphomas. These data indicate that the combination of CIK cells with mAbs can represent a novel approach for the treatment of haematological malignancies. References Franceschetti M, Pievani A, Borleri G, Vago L, Fleischhauer K, Golay J, et al. Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes. Exp Hematol 2009;37:616–28. Cappuzzello E, Tosi A, Zanovello P, Sommaggio R, Rosato A. Retargeting cytokine-induced killer cell activity by CD16 engagement with clinical-grade antibodies. Oncoimmunology 2016 Aug;5(8):e1199311. The research leading to these results has received funding from Fondazione AIRC under IG 2018 - ID. 21354 project - P.I. Rosato Antonio Disclosure Information A. Dalla Pietà: None. E. Cappuzzello: None. P. Palmerini: None. R. Sommaggio: None. G. Astori: None. K. Chieregato: None. O. Perbellini: None. M. Tisi: None. C. Visco: None. M. Ruggeri: None. A. Rosato: None.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小巧的花生完成签到,获得积分10
刚刚
ethely完成签到,获得积分10
刚刚
xuan发布了新的文献求助10
刚刚
刚刚
ky完成签到 ,获得积分10
刚刚
阿伦尼乌斯完成签到,获得积分10
刚刚
刚刚
123发布了新的文献求助10
刚刚
852的应助被淡定的松子采纳,获得10
1秒前
1秒前
喜悦绿旋完成签到,获得积分10
1秒前
Booksiy2完成签到,获得积分10
1秒前
居糯糯完成签到,获得积分10
1秒前
沾沾完成签到,获得积分10
1秒前
2秒前
张宇发布了新的文献求助10
2秒前
梧wu完成签到,获得积分10
2秒前
王灿完成签到,获得积分10
2秒前
积极老四完成签到,获得积分10
2秒前
夹生饭完成签到,获得积分10
2秒前
顾矜的应助被古朵采纳,获得10
3秒前
桐桐的应助被痴情志浩采纳,获得10
3秒前
3秒前
3秒前
hao完成签到 ,获得积分20
4秒前
lsq108完成签到,获得积分10
4秒前
渡人舟的应助被anc采纳,获得10
4秒前
毛毛完成签到 ,获得积分10
4秒前
4秒前
蓝天的应助被phdyhm采纳,获得10
5秒前
vigrous发布了新的文献求助10
5秒前
NexusExplorer的应助被甜筒采纳,获得10
5秒前
笑点低愫完成签到,获得积分10
5秒前
5秒前
WWW完成签到,获得积分10
5秒前
丘比特的应助被qq采纳,获得10
6秒前
joy发布了新的文献求助10
6秒前
crush发布了新的文献求助10
7秒前
7秒前
伸手摘星_浩完成签到 ,获得积分10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8160268
求助须知:如何正确求助?哪些是违规求助? 9555328
关于积分的说明 21727231
捐赠科研通 7750062
什么是DOI,文献DOI怎么找? 3427353
关于科研通互助平台的介绍 2552391
邀请新用户注册赠送积分活动 2471707